NHLBI Workshop
Data Needs for Cardiovascular Events, Management, and Outcomes
Studies Assessing Clinical Management Patterns and/or Patient Outcomes for Heart Failure -
Dr. Harlan Krumholz
Dr. Krumholz has studied extensively the management of
heart failure. He is a clinical coordinator for the National Heart Failure (NHF)
Project, a quality improvement effort launched in 1999 by the then Health Care
Financing Administration (HCFA) – now Centers for Medicare and Medicaid Services
(CMS) – to improve care for Medicare beneficiaries hospitalized with heart
failure. A systematic national sample of fee-for-service Medicare patients
hospitalized for heart failure in 1998-1999 was collected as part of this
project. As a national inpatient program, its baseline quality indicator rates
were focused on rates of ejection fraction documentation and angiotensin-converting
enzyme inhibitor prescription. Data from the project have allowed him and his
collaborators to assess various aspects of quality of care and patient outcomes
concerning heart failure, including the treatment and outcome disparities that
have been observed by gender and by race.
Dr. Krumholz pointed out
that clinical management patterns of heart failure vary. For example, he
speculated that it is likely that the criteria clinicians use to determine
whether to treat a patient with acute exacerbation of heart failure as
outpatient versus inpatient often differ among physicians and by location.
Quality indicators of heart failure management are mostly limited to ejection
fraction documentation and angiotensin converting-enzyme prescriptions – for
which rates are too low for both measures nationally. There do not appear to be
many national quality improvement projects on the horizon that involve the
collection of data that can be used for surveillance. There is a particular
lack of data on outpatient management as well as outpatient self-monitoring of
this disease. There is a great need to assess disparities. He expressed concern
that as new and more invasive treatment technologies such as implantable cardiac
defibrillators become available, the high costs of such treatment may
inadvertently widen the gap of current disparities. To track the impact of
marked anticipated changes in the care of patients with heart failure and the
changing risk patterns of the population, there exists a great need for reliable
surveillance efforts that focus on incidence, treatment, disparities, and
outcome
Back to Workshop Agenda
|